z-logo
open-access-imgOpen Access
Dynein axonemal heavy chain 9 M4374I variation may have an effect on imatinib mesylate resistance in CML
Author(s) -
Mahmut Yildirim,
Levent Şi̇mşek,
Ayşe Gül Zamanı,
Özcan Çeneli̇,
Si̇nan Demi̇rci̇oğlu
Publication year - 2022
Publication title -
medicine international
Language(s) - English
Resource type - Journals
eISSN - 2754-3242
pISSN - 2754-1304
DOI - 10.3892/mi.2022.29
Subject(s) - imatinib , imatinib mesylate , abl , tyrosine kinase , biology , chronic myelogenous leukemia , protein kinase domain , tyrosine kinase inhibitor , cancer research , leukemia , genetics , gene , myeloid leukemia , signal transduction , cancer , mutant

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom